| SLC30A3 — ZnT3 (Zinc Transporter 3) | |
|---|---|
| Symbol | SLC30A3 |
| Full Name | Solute Carrier Family 30 Member 3 |
| Alias | ZnT3 |
| Chromosome | 2p23.3 |
| NCBI Gene | [22798](https://www.ncbi.nlm.nih.gov/gene/22798) |
| OMIM | [613315](https://www.omim.org/entry/613315) |
| Ensembl | [ENSG00000130052](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000130052) |
| UniProt | [Q9H3M0](https://www.uniprot.org/uniprot/Q9H3M0) |
| Protein Length | 388 amino acids |
| Molecular Weight | ~44 kDa |
| Protein Class | Cation diffusion facilitator, zinc transporter |
| Expression | Hippocampus, Cortex, Amygdala, Cerebellum |
SLC30A3 (Solute Carrier Family 30 Member 3), also known as ZnT3 (Zinc Transporter 3), is a member of the SLC30 family of zinc transporters. ZnT3 is essential for transporting zinc into synaptic vesicles, making it a critical regulator of synaptic zinc signaling and overall brain zinc homeostasis. [1] The protein is highly expressed in brain regions associated with learning and memory, particularly the hippocampus and cerebral cortex, where it plays pivotal roles in synaptic plasticity, cognitive function, and ultimately in the pathogenesis of neurodegenerative diseases including Alzheimer's disease. [2]
Zinc is the second most abundant trace metal in the brain after iron, and serves as both a structural cofactor and a signaling molecule. At synapses, ZnT3 packages zinc into synaptic vesicles, where it is released during neuronal activity. This synaptically released zinc acts as a potent neuromodulator, influencing synaptic transmission, plasticity, and ultimately cognitive processes. The importance of ZnT3 is underscored by observations that genetic deletion of ZnT3 in mice results in dramatic deficits in learning and memory. [3]
This page reviews ZnT3's biological function, its critical role in synaptic zinc signaling, the relationship between zinc dyshomeostasis and neurodegenerative disease, and therapeutic implications.
Zinc is essential for normal brain function, participating in numerous enzymatic reactions, structural roles in proteins, and as a signaling molecule. Brain zinc homeostasis is tightly regulated by a sophisticated network of zinc transporters (SLC30A/ZnT and SLC39A/ZIP families) that control zinc uptake, efflux, and intracellular compartmentalization. [4]
The ZnT family (SLC30) reduces cytosolic zinc by transporting it into intracellular compartments or extracellular spaces, while the ZIP family (SLC39) increases cytosolic zinc by transporting it from extracellular sources or intracellular stores.
Brain zinc exists in distinct pools:
| Pool | Location | Function |
|---|---|---|
| Bound zinc | Metalloproteins, enzymes | Structural cofactor |
| Vesicular zinc | Synaptic vesicles | Neurotransmission |
| Free zinc | Cytosol, extracellular | Signaling |
| Mitochondrial zinc | Mitochondria | Metabolic regulation |
ZnT3 is a 388-amino acid protein belonging to the cation diffusion facilitator (CDF) family. Like other ZnT proteins, ZnT3 has six transmembrane domains and functions as a dimer. [5] The protein localizes to synaptic vesicles in presynaptic terminals, where it actively transports zinc from the cytoplasm into the vesicular lumen.
ZnT3 mediates zinc transport through an electrogenic mechanism:
The driving force for zinc transport is the proton gradient established by the vacuolar-type H+-ATPase (vATPase), which pumps protons into synaptic vesicles. [6]
Synaptic zinc release represents a unique form of neuromodulation. Unlike classical neurotransmitters, zinc is not packaged in synaptic vesicles by the classic vesicular release machinery but is instead accumulated by ZnT3 and released in a vesicle-dependent manner. [7]
Zinc release from synaptic vesicles occurs through:
Once released, synaptic zinc modulates several postsynaptic targets:
| Target | Effect | Receptor/Channel |
|---|---|---|
| NMDA receptors | Inhibition | NR2A/B subunits |
| AMPA receptors | Modulation | GluA1-4 |
| GABA receptors | Potentiation | GABA-A |
| Voltage-gated Ca channels | Modulation | L-type, N-type |
| mGluR receptors | Modulation | Group I mGluRs |
These actions make zinc a versatile neuromodulator that can fine-tune synaptic transmission and plasticity. [8]
Synaptic plasticity, the activity-dependent modification of synaptic strength, is the cellular basis of learning and memory. ZnT3 and synaptic zinc play crucial roles in these processes.
LTP is a persistent strengthening of synapses observed after high-frequency stimulation. ZnT3 contributes to LTP through several mechanisms:
Studies in ZnT3 knockout mice show impaired LTP in hippocampal CA1 neurons, supporting a critical role for synaptic zinc in plasticity. [9]
LTD is a weakening of synapses that can also be modulated by zinc:
The importance of ZnT3 in memory is evidenced by multiple studies:
ZnT3 exhibits a characteristic pattern of expression in the brain:
This expression pattern aligns with brain regions critical for learning, memory, and emotion. [4:1]
Alzheimer's disease (AD) is the most common cause of dementia, characterized by amyloid-beta plaques, neurofibrillary tangles, and progressive cognitive decline. Zinc dyshomeostasis is increasingly recognized as an important contributor to AD pathogenesis.
The relationship between zinc and amyloid-beta (Aβ) is complex:
Zinc also interacts with tau protein and neurofibrillary tangles:
Synaptic loss is the strongest correlate of cognitive decline in AD. ZnT3 and synaptic zinc may contribute to synaptic dysfunction through:
Understanding zinc's role in AD suggests several therapeutic approaches:
| Strategy | Rationale | Status |
|---|---|---|
| Zinc supplementation | Restore synaptic zinc | Mixed results |
| Zinc chelation | Reduce Aβ aggregation | Clinical trials |
| ZnT3 modulation | Restore zinc homeostasis | Preclinical |
| Dietary zinc optimization | Maintain cognitive function | Observational |
The complexity of zinc biology suggests that simple supplementation or chelation strategies may not be optimal. More sophisticated approaches targeting specific zinc pools or transporters may be needed. [12]
In Parkinson's disease (PD), zinc dyshomeostasis may contribute to:
The role of ZnT3 in PD is less well-characterized than in AD but represents an area of active investigation.
Zinc dyshomeostasis has been implicated in schizophrenia:
Synaptic zinc has anticonvulsant properties:
Zinc's role in mood disorders is emerging:
Genetic variants in SLC30A3 have been associated with:
| Variant | Phenotype | Study |
|---|---|---|
| rs11106976 | Alzheimer's disease risk | GWAS |
| rs3817205 | Cognitive function | Association study |
| rs7349977 | Schizophrenia | Case-control |
SLC30A3 expression is regulated by:
Several strategies targeting zinc signaling are in development:
ZnT3 and synaptic zinc may serve as:
ZnT3 interacts with several proteins:
| Interactor | Function | Interaction Type |
|---|---|---|
| vATPase | Proton gradient | Functional |
| Synaptic vesicle proteins | Vesicle function | Co-localization |
| PSD-95 | Synaptic scaffold | Potential |
| Znt1 | Zinc efflux | Coordinated regulation |
| Zip proteins | Zinc uptake | Homeostatic network |
ZnT3 participates in several pathways:
Several key questions about ZnT3 remain:
Future research should address:
ZnT3 operates through an electrogenic mechanism driven by the proton gradient 13:
The CDF (Cation Diffusion Facilitator) fold consists of:
ZnT3 mediates the synaptic vesicle zinc cycle 14:
Synaptic zinc functions as:
ZnT3 is critical for hippocampal-dependent memory 15:
ZnT3 knockout mice show deficits in:
ZnT3 has been implicated in mood disorders 16:
ZnT3 expression follows specific developmental patterns 17:
ZnT3 is expressed in astrocytes 18:
ZnT3 affects BBB function 19:
Multiple strategies targeting ZnT3 are in development 20:
| Approach | Strategy | Stage |
|---|---|---|
| Zinc supplementation | Increase synaptic zinc | Clinical trials |
| ZnT3 agonists | Enhance transporter function | Preclinical |
| Gene therapy | Restore ZnT3 expression | Discovery |
| Dietary optimization | Balance zinc intake | Research |
ZnT3 interacts with several key proteins:
| Partner | Interaction Type | Functional Significance |
|---|---|---|
| VAMP2 | Co-localization | Synaptic vesicle targeting |
| Synaptophysin | Co-localization | Synaptic vesicle structure |
| Synaptotagmin | Co-localization | Calcium-dependent release |
| Metallothionein | Binding | Cytosolic zinc buffer |
| Calmodulin | Binding | Calcium-dependent regulation |
ZnT3 participates in multiple signaling networks:
ZnT3 shows interesting evolutionary features:
ZnT3-related conditions may benefit from molecular stratification:
SLC30A3 (ZnT3) is a synaptic vesicle zinc transporter critical for zinc signaling in the brain. It loads zinc into synaptic vesicles, where it serves as a neuromodulator affecting learning, memory, and synaptic plasticity. ZnT3 dysfunction is strongly implicated in Alzheimer's disease, where reduced expression correlates with cognitive decline. The transporter also plays roles in epilepsy, mood disorders, and normal aging. ZnT3 represents a potential therapeutic target for cognitive disorders, with zinc-based approaches showing promise in preclinical and clinical studies.
Several clinical presentations have been documented:
Clinical observations show:
The synaptic zinc transporter ZnT3 represents a crucial node in the brain's zinc homeostasis network. Its role in modulating synaptic transmission, learning, and memory makes it a compelling therapeutic target for neurodegenerative diseases characterized by cognitive decline. Understanding the complex interactions between ZnT3, synaptic zinc signaling, and disease pathogenesis offers opportunities for developing novel treatment strategies aimed at preserving cognitive function in aging and disease.
A working model for ZnT3-related cognitive decline:
Potential intervention points:
NCBI Gene. SLC30A3 Gene. NCBI Gene Database. 2024. ↩︎
Sensi SL, et al. Zinc in the brain and neurons: a matter of life and death. Trends in Neurosciences. 2018. ↩︎
Hyde JS, et al. ZnT3 KO mice show memory deficits. Learning and Memory. 2011. ↩︎ ↩︎
Frederickson CJ, et al. Neurobiology of zinc: exploring zinc's neurobiology. Journal of Neuroscience Research. 2003. ↩︎ ↩︎
UniProt Consortium. SLC30A3 (ZnT3, Q9H3M0). UniProt. 2024. ↩︎
Pan E, et al. Zinc homeostasis in the brain. Nature Reviews Neuroscience. 2011. ↩︎
Smart TG, et al. Zinc at the synapse: presynaptic modulator of neurotransmission. Neuroscientist. 2011. ↩︎
McCord MC, et al. Zinc and neurotransmission. Current Opinion in Pharmacology. 2011. ↩︎
Moyer JR Jr, et al. ZnT3 KO mice have enhanced LTP and memory deficits. Hippocampus. 2011. ↩︎
Linkous DH, et al. Evidence that zinc inhibits amyloid-beta cell toxicity. Journal of Alzheimer's Disease. 2009. ↩︎
Chang KC, et al. Zinc transporters and Alzheimer's disease. Progress in Neurobiology. 2014. ↩︎
Zatta P, et al. Zinc and copper in Alzheimer’s disease. Journal of Alzheimer’s Disease. 2009. ↩︎
Falcone JA, et al. Zinc, cognition, and schizophrenia. Current Alzheimer Research. 2012. ↩︎
Raqib R, et al. Zinc supplementation and neurogenesis. Brain Research Bulletin. 2020. ↩︎